Dayondon, Richard B.
HRN: 24-31-51 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/01/2024
CEFUROXIME 1.5GM (VIAL)
01/01/2024
01/08/2024
1.5G
IV
Q8hrs
Lacerated Wound Secondary To VA
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes